askthedoctor “Scientific” Tests T
Take a Second Look Before believing a claim based on a “scientific study,” think about how and why the study was done. If the study was done to help sell the product, be skeptical.
56 MILITARY OFFICER JANUARY 2015
Many products are advertised as “scientifi cally tested.” But as Rear Adm. Joyce Johnson, D.O., explains, not every study is objective, nor should you believe the results.
There are stringent regulatory re- quirements for the testing and approval of pharmaceuticals and some other products, but health claims for items such as athletic gear, exercise equipment, hair products, etcetera don’t require such controlled data. “Scientifi cally tested” implies some sort of study was performed, but it does not mean a health claim is true; it’s possible to design a study specifi cally to get the desired result. There are several ways to infl uence the
results of a study. Questions in a multiple- choice survey can be worded to skew an answer. A survey might require a person’s name and other identifying information (often to get a payment for completing the survey) and make respondents hesitate to provide negative answers. If people testing a product are briefed about its advantages before using it, the power of suggestion in- fl uences their responses. Some studies don’t have enough participants for statistical va- lidity, or the participants selected are those most likely to give the desired response — such as employees of the manufacturer. What factors make a study more valid?
First, the study population should be ap- propriate (e.g., to test whether a vaccine will work against a certain disease, the study population should be people who are susceptible and exposed to the dis- ease). Second, study participants should be selected randomly from that study pop- ulation. Third, the study design and how it is followed are critical, as they can add bias and make the results invalid.
A placebo-controlled study includes
at least two groups of participants, one receiving the test product and the other (the control group) receiving a placebo. The placebo should be similar to the test product, so study participants are unable to determine which they are receiving. A placebo could be a sugar pill, an injection of salt water, or some other harmless but fake treatment. Sometimes the “placebo” is the standard treatment for a disease. For example, it would be unethical to give a diabetic patient an injection of salt water while testing a new type of insulin. In- stead, the control group would receive the standard insulin treatment. A double-blind study is one in which neither the medical team (investigators) nor the patients (subjects) knows who is getting the test product or a placebo. An independent group collects the data and monitors results. This design eliminates much testing bias. Occasionally, a study population has extremely diff erent results from the control group. A study might end early if the study product is found to be dangerous or (rarely) if the study product is found to be signifi cantly better than the control product and it is determined to be unethical to deprive the control population and others of the study product.
MO
— Rear Adm. Joyce Johnson, USPHS (Ret), D.O., M.A., is a health care consultant in Chevy Chase, Md. Find more health and wellness resources at
www.moaa.org/wellness. For sub- mission information, see page 6.
PHOTO: STEVE BARRETT
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96